Predictors and moderators in internet-delivered therapies for adolescent depression: Results from a randomized non-inferiority trial
AI Summary
Higher self-compassion predicted significantly steeper symptom improvement across both internet-delivered CBT and psychodynamic therapy; the only significant predictor.
Comorbid anxiety moderated treatment outcome: higher anxiety linked to greater improvement in IPDT versus ICBT; no difference at average levels, ICBT superior at lowest anxiety.
Few baseline moderators were identified; baseline variables may guide treatment selection but findings require replication to establish clinical utility.
Psychother Res. 2026 Jun 23:1-15. doi: 10.1080/10503307.2026.2686693. Online ahead of print.
ABSTRACT
Internet-delivered psychotherapies show promise for adolescent major depression (MDD), but little is known about which baseline characteristics predict improvement or moderate differential effects between internet-delivered cognitive-behavioral therapy (ICBT) and psychodynamic therapy (IPDT). This study examined pretreatment predictors and moderators of symptom change in a randomized trial comparing the treatments.
This secondary analysis used data from a non-inferiority trial (n = 272) in which adolescents with MDD received 10 weeks of guided ICBT or IPDT. Mixed-effects models tested predictors and moderators of change in self-rated depression. Anxiety symptoms, length of depressive episode, emotion regulation, personality disorder severity, attachment, self-compassion, suicidal ideation, and baseline depression were examined as predictors and moderators.
Higher self-compassion predicted steeper improvement across treatments, as the only significant predictor. Comorbid anxiety moderated outcome where higher anxiety was associated with significantly greater improvement in IPDT relative to ICBT, with no difference at average levels. At the lowest levels of anxiety, ICBT showed significantly better outcomes. No other significant moderators emerged.
Findings suggest that baseline variables may influence the rate of improvement in internet-delivered therapy for adolescent MDD, as well as help guide treatment selection. Replication is needed to establish the clinical utility of these variables.
JAMA Netw Open. 2026 Jun 1;9(6):e2619121. doi: 10.1001/jamanetworkopen.2026.19121.ABSTRACTIMPORTANCE: Ketamine exerts rapid antidepressant effects. However, currently available ketamine-based treatments are associated with dissociative and cardiovascular adverse...
JAMA Psychiatry. 2026 Jun 24. doi: 10.1001/jamapsychiatry.2026.1100. Online ahead of print.ABSTRACTIMPORTANCE: Neuroimaging is prevalent in psychiatric research, but there is limited evidence that it improves...
JAMA Psychiatry. 2026 Jun 24. doi: 10.1001/jamapsychiatry.2026.1674. Online ahead of print.ABSTRACTIMPORTANCE: Revealing neurobiological markers of antipsychotic nonresponse in psychosis may aid outcome prediction and inform...
